Dipraglurant,也被称为ADX-48621,是mGlu5受体的负变构调制器,该受体正处于Addex疗法的开发中,用于治疗帕金森病左旋多巴诱导的运动障碍(PD-LID)。
For research use only. We do not sell to patients.
| Name | Dipraglurant |
|---|---|
| Iupac Chemical Name | 6-Fluoro-2-[4-(2-pyridinyl)-3-butyn-1-yl]imidazo[1,2-a]pyridine |
| Synonyms | ADX-48621; ADX48621; ADX 48621; Dipraglurant |
| Molecular Formula | C16H12FN3 |
| Molecular Weight | 265.2914 |
| Smile | FC1=CN2C(C=C1)=NC(CCC#CC3=NC=CC=C3)=C2 |
| InChiKey | LZXMUJCJAWVHPZ-UHFFFAOYSA-N |
| InChi | InChI=1S/C16H12FN3/c17-13-8-9-16-19-15(12-20(16)11-13)7-2-1-5-14-6-3-4-10-18-14/h3-4,6,8-12H,2,7H2 |
| CAS Number | 872363-17-2 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | 类白色至白色固体 |
|---|---|
| Purity | >98% |
| Storage | 短期可在0-4度保存,数天至数月;长期可在-20度保存三年。 |
| Solubility | 可溶于DMSO |
| Handling | |
| Shipping Condition | 可在常温下运输 |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |